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Objective: The frequency of reoperation for mitral valve diseases with chronic 
atrial fibrillation has increased steadily. This study examined the rationale for 
using the Cox maze operation for atrial fibrillation during redo mitral valve 
operations. Methods: Between June 1992 and July 1995, we performed the maze 
procedure in 42 patients as a concomitant operation with redo mitral valve 
surgery (maze group). Associated procedures were tricuspid valve surgery in 
27 patients and aortic valve surgery in 15 patients. The mean age at operation 
was 57.3 - 9.7 years, and the mean interval from the previous operation was 
14.3 --- 10.5 years. The mean follow-up period after the maze procedure was 
25.5 - 10.8 months. Atrial fibrillation was present at the time of the previous 
operation in 29 patients (69%). Results: Neither hospital death nor late death 
occurred. Sinus rhythm was regained in 28 patients (67%), and an atrial 
A-wave was detected in 21 patients (50%) by pulsed Doppler study. Patients in 
whom sinus rhythm was restored had a shorter history of atrial fibrillation 
(9.0 - 6.0 years vs 15.9 -+ 4.6 years, p = 0.0009), a larger f-wave on lead V1 of 
the electrocardiogram (0.18 -+ 0.10 mV vs 0.10 - 0.08 mV, p = 0.017), and a 
smaller cardiothoracic ratio (63% -+ 8% vs 67% - 5%,p = 0.049) than patients 
with persistent atrial fibrillation. During the same period, 54 patients under- 
went mitral valve reoperation without he maze procedure (control group). The 
aortic crossclamp and cardiopulmonary b pass times were slightly longer (p = 
0.048 and p = 0.012) in the maze group (133 - 28 minutes and 221 - 43 
minutes) than in the control group (126 - 65 minutes and 197 -+ 78 minutes). 
There was no significant difference in the amount of chest tube drainage or 
transfusion between the two groups (890 -+ 510 ml and 2120 --- 1600 ml, 
respectively, in the maze group and 840 --+ 480 ml and 2140 --- 1760 ml, 
respectively, in the control group). It was not necessary to reopen the chest for 
bleeding significantly more often in one group than in the other (14% in the 
maze group and 7% in the control group), and it was possible to operate 
without transfusion with the same frequency in the two groups (17% in the 
maze group and 20% in the control group). Conclusion: These results suggest 
that the maze procedure should be considered in selected patients who have a 
high possibility of regaining sinus rhythm during redo mitral valve operations. 
(J Thorac Cardiovasc Surg 1996;112:1216-22) 
T he incidence of mitral valve reoperation has recently increased a;2 owing to the palliative na- 
ture of  the initial mitral valve repair of closed or 
open mitral commissurotomy. Progression of the 
aortic or tricuspid valve disease, structural deterio- 
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ration of the bioprosthetic valve, and infection of the 
prosthetic valve are other causes for reoperation. 
Atrial fibrillation (AF) is frequently associated in 
these patients, and sinus rhythm seldom returns 
even after successful repair of the mitral valve 
lesion. With persistent AF, the risk of thromboem- 
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Table I. List of operations done before the maze 
procedure 
Table II. Simultaneous operations with the maze 
procedure 
Operation No. of patients Operations No. of patients 
MVR 15 
OMC for MS 8 
Mitral valve repair for MR 6 
MVR and AVR 4 
CMC 3 
Mitral valve repair and ASD closure 3 
OMC and AVR 2 
Mitral and aortic valve repair 1 
Total 42 
All valve replacement was performed with a biologic valve xcept in one 
case. Two patients had undergone open mitral commissurotomy previously. 
MVR, Mitral valve replacement; OMC, open mitral commissurotomy; MS, 
mitral stenosis; MR, mitral regurgitation; AVR, aortic valve replacement; 
CMC, dosed mitral commissurotomy; ASD, atrial septal defect. 
bol ism increases and the loss of left atrial  contrac- 
t ion impairs left ventr icular function. 
The maze procedure  was developed by Cox, 3 and 
its modif icat ions have been widely per formed uring 
the past few years as a concomitant  procedure with 
mitral  valve operat ions.  4-9 However,  conduct ing the 
maze procedure  s imultaneously with redo mitral  
valve surgery is still controversial,  because redo 
valve operat ions have a considerably higher opera-  
tive mortal i ty than pr imary valve operat ions.  In the 
present  study, we examined the efficacy and risk of 
the maze procedure  for AF  during redo mitral  valve 
surgery. 
Patients and methods 
Patients. Between June 1992 and July 1995, 42 patients 
with AF underwent redo mitral valve operations with the 
maze procedure (maze group). The patients are com- 
posed of 21 men and 21 women, and their ages at 
operation ranged from 23 to 71 years with an average of 
57.3 _+ 9.7 years (mean _+ standard deviation). The 
interval from the previous operation was 1.4 to 33 years 
with an average of 14.3 _+ 10.5 years. The duration of AF  
ranged from 10 months to 29 years with an average of 
11.3 ± 3.4 years. AF was already present at the time of the 
previous operation in 29 patients (69%). The previous 
operations are listed in Table I. Two patients underwent a 
third operation. The causes of redo mitral valve opera- 
tions were bioprosthetic valve degeneration i  19 patients, 
mitral regurgitation i 10, mitral restenosis with regurgi- 
tation in 9, and pure mitral restenosis in 4. Concomitant 
valve diseases were aortic valve disease in 14 patients and 
tricuspid regurgitation i 23. Forty patients had chronic 
sustained AF, and 2 patients had paroxysmal AF or atrial 
flutter. Preoperative lectrocardiography (ECG) was re- 
corded, and the voltage of the f-wave in lead V 1 was 
measured. New York Heart Association functional class 
was I or II in 22 patients and III or IV in 20. The 
cardiothoracic ratio was also measured before the opera- 
MVR and TAP 20 
MVR and AVR with or without TAP 8 
MVR 7 
MVR with other procedures 3 
Mitral valve repair with or without 3 
other valve repair 
Mitral valve repair and AVR 1 
Total 42 
All valve replacement was performed with a mechanical valve. Three 
patients underwent only valve repair. All abbreviations are the same as in 
Table I. TAP, Tricuspid annuloplasty. 
tion, and the left atrial size was determined by echocar- 
diography. 
Simultaneous procedures with the maze operation are 
listed in Table II. All valves were replaced with a mechan- 
ical valve. As for the maze procedure, we performed 
Kosakai's modified maze procedure in 37 patients, the 
modified Cox maze II procedure in 2, and the modified 
Cox maze III procedure in 3. The precise technique of the 
operation was described previously, v' 10 Cardiopulmonary 
bypass was instituted with ascending aortic cannulation 
and bicaval cannulation after partial release of the adhe- 
sion. The heart was completely dissected out for the maze 
procedure before the aorta was crossclamped. All patients 
had mild systemic hypothermia (29 ° to 32 ° C), antegrade 
infusion of St. Thomas' Hospital cardioplegic solution 
every 30 minutes, and topical cooling with ice slush. In five 
patients with severe adhesions on the left side of the left 
atrium, the latter was not completely separated from the 
left pulmonary veins. Cryoablation was performed on the 
undivided edge of that side. The right atrial procedure was 
performed before crossclamping of the aorta and arrest of 
the heart with St. Thomas' Hospital cardioplegic solution. 
Aprotinin was used during cardiopulmonary b pass in 17 
patients, with an initial administration of 1 million units 
followed by 1/2 million units every hour until the termina- 
tion of bypass. When the left and right atrial appendages 
were already resected, the base of the each appendage was 
merely cryoablated. 
Control group. The patients who underwent redo mi- 
tral valve operations without the concomitant maze pro- 
cedure during the same period (control group) were 
compared with the maze group. This control group con- 
sisted of 54 patients of matching age, sex, severity of 
diseases, and other profiles (Table III). Forty-one patients 
(76%) had AF. The reason for avoiding the maze proce- 
dure in these patients was no f-wave or low ventricular 
rate (or both), left atrial wall calcification, serious com- 
plication, and lack of an informed consent form for the 
maze procedure in the earlier period. The reasons for 
redo mitral valve surgery were bioprosthetic valve degen- 
eration in 41 patients, mitral regurgitation i  5, mitral 
restenosis with regurgitation i 5, and pure mitral reste- 
nosis in 3. Concomitant valve diseases were aortic valve 
disease in 25 patients and tricuspid regurgitation i 25. 
The operative procedures were mitral valve replacement 
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Table I I I. Patient profile of the maze and the 
control groups 
Maze Control 
group group 
Characteristics (n = 42) (n = 54) p Value 
Age at operation (yr) 57.3 -+ 9.7 61.2 _+ 10.0 NS 
Interval after previous 14.3 + 10.5 10.8 + 3.3 NS 
operation (yr) 
Sex (M/F) 21/21 23/31 NS 
NYHA class III, IV 20 (48%) 30 (56%) NS 
Rheumatic heart disease 36 (86%) 49 (91%) NS 
Third time operation 2 (4.8%) 4 (7.4%) NS 
Presence of tricupsid lesion 23 (55%) 25 (46%) NS 
Presence of aortic lesion 14 (33%) 25 (46%) NS 
Presence of AF 
Last operation 29 (69%) 36 (67%) NS 
Present operation 40 (95%) 41 (76%) NS 
Cardiothoracic ratio (%) 64 + 7 67 -+ 9 NS 
Cardiac measurement by 
echocardiography 
LAD (ram) 57 + 8 58 + 14 NS 
LVEDD (mm) 52 _+ 9 52 _+ 9 NS 
LVESD (mm) 35 + 9 34 + 9 NS 
Blood examination 
Creatinine (mg/dl) 0.8 _+ 0.2 1.2 + 2.8 NS 
BUN (mg/dl) 17 _+ 5 21 _+ 9 NS 
Hemoglobin (g/dl) 12.6 _+ 2.3 12.0 + 2.2 NS 
Platelet (×1000/txl) 186 -+ 62 147 + 60 NS 
Total bilirubin (mg/dl) 1.2 + 0.7 1.5 _+ 0.9 NS 
Aprotinin use 17 (40%) 25 (46%) NS 
MF, Male/female; NYHA, New York Heart Association; AF, atrial fibril- 
lation; LAD, left atrial dimension; LVEDD, left ventricular end-diastolic 
dimension; LVESD, left ventricular end-systolic dimension; BUN, blood 
urea nitrogen; NS, not significant. 
(MVR) with tricuspid annuloplasty in 15 patients, MVR 
and aortic valve replacement with or without tricuspid 
annuloplasty in 18, MVR in 7, MVR and tricuspid valve 
replacement in 7, MVR, aortic valve replacement, and 
tricuspid valve replacement in 3, MVR and aortic valvu- 
loplasty in 2, and mitral valvuloplasty in 2. All valves were 
replaced with a mechanical valve except in one case in 
which double valve replacement with porcine bioprosthe- 
ses was done. 
Data collection. The status of patients was determined 
by referring to the medical records and correspondence 
with the responsible physicians. All the cardiac and non- 
cardiac events were recorded in detail. Patients were 
followed up by ECG, chest roentgenogram, and echocar- 
diography with pulsed Doppler study every 3 months. We 
defined the sinus rhythm on ECG 6 months after the 
operation if the P-wave was present. The presence of an 
A-wave through the mitral and tricuspid valves by pulsed 
Doppler study was decided by the independent analysis of 
the cardiologists. The mean follow-up period after the 
redo mitral valve operation was 25.5 -+ 10.8 months for 
the maze group and 29.2 _+ 11.3 months for the control 
group. Three patients in the maze group and two patients 
in the control group were free from anticoagulation 
therapy. 
Statistical analysis. Continuous variables were com- 
pared by the Wilcoxon rank sum test, and the discrete 
variables were analyzed by Fisher's exact est. Differences 
were considered statistically significant when the p value 
was less than 0.05. 
Results 
No hospital death or late deaths occurred in the 
maze group. Two reoperations were done for resid- 
ual mitral regurgitation and one redo MVR for 
prosthetic valve endocarditis. Sinus rhythm was re- 
stored in 28 patients (67%), and an atrial A-wave 
was detected in 21 patients (50%) by pulsed Dopp- 
ler study. In five patients, an A-wave was observed 
only in the transtricuspid flow. AF persisted in eight 
patients. Other rhythms were persistent atrial flutter 
in two and junctional rhythm in four, three of whom 
eventually required implantation of a DDD pace- 
maker. Among 29 patients who had AF after the 
previous operation, sinus rhythm was restored in 
12 (41%). Of five patients whose pulmonary veins 
were not completely dissected from the left 
atrium on the left side with the substitution of 
cryoablation, none regained normal sinus rhythm. 
Patients who regained sinus rhythm had a shorter 
history of AF (9.0 _ 6.0 years vs 15.9 -+ 4.6 years, 
p = 0.0009), a larger f-wave on lead V1 of the ECG 
(0.18 _+ 0.10 mVvs  0.10 _+ 0.08 mV, p = 0.017), and 
a smaller cardiothoracic ratio (63% _+ 8% vs 67% _+ 
5%, p = 0.049) than patients with persistent AF 
(Table IV). 
The aortic crossclamp time and eardiopulmonary 
bypass time were slightly longer (p = 0.048 andp = 
0.012) in the maze group (133 _+ 28 minutes and 
221 _+ 43 minutes) than in the control group (126 _+ 
65 minutes and 197 _+ 78 minutes). The median 
aortic crossclamp time was 136 minutes in the maze 
group and 115 minutes in the control group. The 
median cardiopulmonary b pass time was 216 min- 
utes in the maze group and 189 minutes in the 
control group. There was no significant difference in 
the amount of chest tube drainage or transfusion 
between the two groups (890 _+ 510 ml and 2120 _+ 
1600 ml, respectively, in the maze group and 840 _+ 
480 ml and 2140 _+ 1760 ml, respectively, in the 
control group). It was not necessary to reopen the 
chest for bleeding significantly more often in one 
group than in the other (14% in the maze group and 
7% in the control group), nor was there a difference 
between groups in the need for transfusion (17% in 
the maze group; 20% in the control group) (Table 
V). There were no significant differences in mortal- 
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Table IV. Comparison between patients with and without restored sinus rhythm 
Variables Sinus rhythm (+) Sinus rhythm ( - )  p Value 
No. of patients 28 14 
Age at operation (yr) 57.8 -+ 10.0 56.1 ± 9.3 NS 
Sex (M/F) 16/12 5/9 NS 
Rheumatic heart disease 23 (82%) 13 (94%) NS 
Duration of AF (yr) 9.0 ± 6.0 15.9 ± 4.6 p = 0.0009 
Presence of AF at the previous operation 21 (75%) 8 (57%) NS 
NYHA class III, IV 14 (50%) 6 (43%) NS 
Voltage of f-wave on lead V 1 (mV) 0.18 _+ 0.10 0.10 -+ 0.08 p = 0.017 
Cardiothoracic ratio (%) 63 _+ 8 67 ± 5 p - 0~049 
Presence of tricuspid lesion 13 (46%) 10 (71%) NS 
Cardiac measurements by echocardiography 
before the maze procedure 
LAD (mm) 57 ± 9 57 _+ 6 NS 
LVEDD (mm) 52 + 10 52 _+ 10 NS 
LVESD (mm) 35 ± 8 35 _+ 9 NS 
Cardiac measurements by echocardiography 
after the maze procedure 
LAD (mm) 43 ± 6 45 _+ 6 NS 
LVEDD (ram) 48 ± 9 49 _+ 9 NS 
LVESD (mm) 35 ± 9 36 _+ 12 NS 
M/F, Male/female; AF, atrial fibrillation; LAD, left atrial dimension; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end~syst01ic 
dimension; NS, not significant. 
Table V. Results of operations in the maze and control groups 
Maze group Control group 
(n = 42) (n = 54) p Value 
ACC time (rain) 133 ± 28 [136] 121 _+ 44 [115] p = 0.048 
CPB time (rain) 211 +_ 43 [216] 197 ± 78 [189] p = 0.012 
Chest tube drainage* (ml) 890 -+ 510 [800] 840 ± 480 [820] NS 
Blood transfusion (ml) 2120 _+ 1600 [2150] 2140 ± 1760 [2090] NS 
No transfusion 7 (17%) 11 (20%) NS 
Mortality 
Hospital death 0 (0%) 4 (7.4%) NS 
Late death 0 (0%) 2 (3.7%) NS 
Morbidity 
Chest reopening for bleeding 6 (14%) 4 (7.4%) NS 
Mediastinitis 0 (0%) 2 (3.7%) NS 
Late complications 
Thromboembolism 0 (0%) 1 (1.9%) NS 
CSH 2 (4.8%) 0 (0%) NS 
Infective ndocarditis 1 (2.4%) 1 (1.9%) NS 
Reoperation 2 (4.8%)t 2 (3.7%)$ NS 
Brackets indicate median value. ACC, aortic rossclamp; CPB, cardiopulmonary bypass; CSI4, chronic subdural hematoma. 
*For 24 hours after admission i to the intensive care unit. 
tResidual mitral regurgitation. 
:~Perivalvular eakage. 
ity, morbidity, and the incidence of late complica- 
tions between the two groups. 
Discussion 
The purpose of the maze procedure is to convert 
AF to sinus rhythm and to restore the atrial booster 
pump function. In the present study, 67% of the 
patients regained sinus rhythm, a lower percentage 
than that achieved during maze procedures per- 
formed during the initial mitral valve operation in 
our institute (84%, unpublished data). The pulsed 
Doppler study detected left atrial contraction in 
38% and right atrial contraction in 50%. The inci- 
dence of A-wave detection was 81% for the transtri- 
cuspid flow and 69% for the transmitral flow in 
patients who underwent the maze procedure with 
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the primary mitral valve operation (unpublished 
data). Therefore satisfactory ECG and hemody- 
namic effects of the maze procedure were less 
frequent after the redo mitral valve operation than 
after the primary mitral valve operation. This is a 
significant problem, because thromboembolism re-
mains a risk in patients in whom sinus rhythm and 
atrial contraction are not restored. 
There were three kinds of failure in sinus rhythm 
recovery. One kind is sinus node dysfunction, which 
necessitates atrial pacemaker implantation. Preser- 
vation of the arterial supply to the sinus node by 
modifying the incision could not prevent sinus node 
dysfunction completely. Sinus node dysfunction may 
be caused by damage to the sinus node itself by 
rheumatic degeneration, surgical trauma, persistent 
high atrial pressure, or right atrial enlargement such 
as after a Senning or Fontan operation. TM12 An- 
other type is AF and atrial flutter, which were 
presumably the result of a shorter atrial refractory 
time or microreentry circuits. Another possibility is 
the less than optimal substitution ofcryoablation for 
a surgical incision, especially in patients with severe 
adhesions in whom the left atrium could not be 
separated from the left pulmonary veins. 
Sacrifice of Bachmann's bundle may delay the 
conduction from the sinus node to the left atrium, 
and the left ventricle may contract at the same time 
as the left atrium. 13 The absence of atrial contrac- 
tion was probably due to a fibrotic and calcified 
degeneration of the left atrium. This may explain 
the more frequent detection of the A-wave in the 
transtricuspid flow by the pulsed Doppler study than 
in the transmitral flow because our modified maze 
procedure--similar to the Cox maze III proce- 
dure-does not sacrifice Bachmann's bundle. Ac- 
cording to a preliminary study by the cardiologists in
our institute, left atrial contraction appeared even 6 
months after the maze operation, and the left atrium 
may regain contraction with time. Williams and 
associates 14 reported that right atrial-right ventric- 
ular synchrony with preserved right atrial function 
could result in forward cardiac output regardless of 
the left atrium in the animal model. The right atrial 
contraction is thought o contribute to a higher 
cardiac output and lower central venous pressure. 
The risk factors for failure to regain sinus rhythm 
were duration of AF, amplitude of f-wave in lead V1, 
and cardiothoracic ratio. These results almost agree 
with those of our previous tudies]' lO The dimen- 
sion of the left atrium by echocardiography was not 
related to the recovery of the sinus rhythm in the 
present study. However, cardiothoracic ratio was 
reflected by the enlargement of the left and right 
atria. An enlarged left atrium may induce AF even 
after the atrium has been divided by incision or 
cryoablation because the separate compartments of 
the atrium were still large enough to make a reentry. 
Therefore we resected the left atrium and took 
enough bite stitches o as not to make the segment 
longer than 4 cm. The f-wave is a sum of the total 
electrical activity of the atrial muscles, and the 
amplitude is thought to reflect degree of degenera- 
tion of the atrium. Tricuspid regurgitation was ob- 
served slightly more frequently in patients without 
sinus rhythm, but the difference was not statistically 
significant. Damage to the sinus node and right 
atrium may result from pressure and volume over- 
load in these patients. 
Reoperative mitral valve surgery is usually asso- 
ciated with a higher operative mortality and mor- 
bidity than the primary mitral valve operation. 
There was no hospital death in the maze group. The 
incidence of morbidity was similar to that in the 
control group. The aortic crossclamp time and car- 
diopulmonary b pass time were significantly onger 
in the maze group than in the control group, but 
postoperative bleeding, amount of transfusion, and 
other types of morbidity were similar in the two 
groups. Reopening the chest for bleeding was nec- 
essary slightly more often in the maze group, but the 
difference was not statistically significant. The maze 
procedure necessitated complete dissection of the 
entire heart from the surrounding tissue. Especially 
in reoperations after closed mitral commissurotomy, 
the pericardium and the pleura were sometimes 
deficient, and the left lung was tightly adherent to 
the heart. The risk of bleeding before and after the 
redo mitral valve operation increased if the adhe- 
sion was very tight. We used aprotinin in 40% of 
patients, because it reduces intraoperative and post- 
operative bleeding. 15 Thus we are able to avoid or 
reduce blood transfusion with prophylactic use of 
aprotinin in the maze procedure. 
Careless elevation of the cardiac apex during the 
dissection may increase the risk of tearing the left 
ventricle if the strut of the bioprosthetic valve is 
incorporated into the ventricular muscle. 16 Never- 
theless, dissection of the whole heart had some 
merit. In addition to cardioplegic solution, ice slush 
on the surface of the ventricle can result in satisfac- 
tory myocardial preservation with mild hypother- 
mia. Mitral exposure was as good as that obtained 
with the transseptal superior approach, which may 
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sacrifice the right and left sinus node arteries, s7 
Removing air from the heart was easy, and bypass 
time after aortic unclamping could be shortened. 
The median aortic crossclamp and cardiopulmonary 
bypass times in the maze group were only 20 to 30 
minutes longer than in the control group. Although 
the maze procedure usually took an additional 40 to 
50 minutes, MVR could be performed as easily and 
quickly as with ',bench" surgery. 
No cardiac complications were related to the 
maze procedure itself, and no thromboembolic ep- 
isode was detected though the follow-up period was 
short. Chua and associates i  reported that 80% of 
patients with preoperative chronic AF had persis- 
tent AF rhythm after mitral valve repair with a mean 
follow-up of 2.6 years. The remaining 20% of pa- 
tients with sinus rhythm or paroxysmal AF might be 
treated with antiarrhythmic drugs, which are proar- 
rhythmic by themselves. In our institute, the defi- 
brillation rate in patients who underwent only a 
mitral valve operation was also 15% in 1988 and 
1989. 
The drawback of the present study was that the 
maze group and the control group were not sepa- 
rated at random. In principle, we recommended the 
maze procedure for all patients with AF in the 
control group, irrespective of the size of the left 
atrium and the history of AF. However, we could 
not obtain informed consent from the patients, 
especially in the early period of the present study, 
because the data were not convincing enough. The 
other problem was the relatively short follow-up 
period of 21/2 years. We have to follow up the 
patients for 5 to 10 years to assess the efficacy of the 
maze procedure for the prevention of thromboem- 
bolism and bleeding in patients with mechanical 
valve replacement and anticoagulation therapy. 
Comparing the benefits and efficacy versus the 
risk of the maze procedure during the redo mitral 
valve operation, the maze procedure should be 
restricted to patients with a high possibility of 
recovering sinus rhythm and to patients who un- 
dergo mitral valve repair without receiving antico- 
agulant therapy. McCarthy and associates 6 recom- 
mended that the maze procedure should be 
performed in patients with good ventricular func- 
tion. However, inasmuch as atrial contraction is very 
important to the failing heart, we think that the 
maze procedure should be performed concomitantly 
with MVR while preserving the mitral valve appa- 
ratus for moderately depressed left ventricular func- 
tion. 
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Discussion 
Dr. Fred A. Crawford (Charleston, S.C.). Recently at the 
meeting of the American Surgical Association Jim Cox 
summarized his entire series of maze procedures. Overall, 
93% of the patients were cured of AF by the operation 
alone, and the remaining 7% were cured by the addition 
of one drug; 94% were found to have left atrial function 
after the operation. 
Because of the success in patients with isolated AF, the 
maze procedure has now been combined with other 
procedures in selected patients. Dr; Kobayashi and his 
colleagues have previously reported the combination of 
the maze procedure with a variety of other cardiac 
procedures, and today they report performing a modifi- 
cation of the maze procedure in 42 patients at the time of 
reoperative mitral vane surgery. There were no deaths in 
this series, attesting to their operative skills. However, 
only two thirds of the patients regained sinus rhythm as 
compared with all of those in Cox's series, 
It is clear that the procedure performed by Dr. Koba- 
yashi and his colleagues i significantly different from the 
current modification of the maze procedure performed by 
Cox. One effect of these changes is to shorten the time 
required to perform the operation; for example, in this 
series it only added 7 minutes to the crossclamp time and 
24 minutes to the total pump time. Cox believes that a key 
part of the maze procedure is the vertical incision that 
connects the pulmonary vein encircling incision to the 
mitral valve anulus and, in particular, the ablation of all 
conduction across the coronary sinus. In fact, in his early 
patients with postoperative AF, failure was believed to be 
due at the time of restudy to persistent conduction in this 
area. Dr. Kobayashi does not perform this incision at all; 
instead, he replaces it with extensive cryoablation. Dr. 
Kobayashi, do you believe that the relatively high failure 
rate in your series is related to this or to other modifica- 
tions that you have made to the maze procedure, or do 
you believe that it is related to something else, perhaps the 
relatively long history of AF and the marked dilatation of 
the left atrium in these patients? If it i s  due to your 
modifications, have you considered changing so that you 
perform the operation more as Cox has described? If it is 
due to the duration of AF or to left atrial size, is there 
some subset of patients that can be identified before the 
operation in whom the maze is more likely to be unsuc- 
cessful and in whom it should therefore not be per- 
formed? Accordingly, what are your current criteria for 
performing the maze procedure at the time of redo mitral 
valve surgery and also for those patients with AF under- 
going a first-time mitral valve procedure? 
Finally, one of the advantages of the maze operation is 
not only to return the patient o sinus rhythm but to return 
atrial transport function to normal. Left atrial contrac- 
tions were identified in only 38% of your patients. Is the 
addition of the maze procedure at the time of redo mitral 
valve surgery worth the extra effort and potential risk to 
the patient for this small gain? 
Dr. Kobayashi. Thank you very much, Dr. Crawford, 
for the very important comments. These were consecutive 
patients; we did not select hem according to the size of 
the left atrium or the length of their histories. We were a 
little less Successful in restoring sinus rhythm was Dr. Cox. 
These patients had long-term AF with rheumatic heart 
disease, and I think that is the reason for the difference. 
Sinus rhythm was restored in 84% of the patients after 
primary mitral valve surgery, so I think these patients had 
more advanced rheumatic heart disease. 
About the criteria: I did not select the patients. If we 
had select patients according t o certain criteria, for exam- 
ple, left atrial size smaller than 60 mm in diameter, 
cardiothoradc ratio smaller than 65%, f-wave larger than 
2.0 mm in lead V1, and duration of AF less than 10 years, 
i think the success rate would be more than 95%. The 
advantage of the maze procedure is not only the recovery 
of sinus rhythm but also regaining the atrial booster pump 
function, which is very important for the impaired left 
ventricular function. In the patients who underwent 
MVR, the maze procedure is as important as the preser- 
vation of the mitral valve apparatus, even if the patients 
have to have warfarin sodium. If the patient is restored to 
sinus rhythm, we will be able to use a relatively low 
prothrombin time international normalized ratio with 
warfarin and decrease the incidence of bleeding. 
Dr. Joao Q. Melo (Camaxide, Portugal). Dr. Kobayashi, 
two years ago your group presented to this Association a
much higher rate of success after the maze operation in 
patients with mitral disease. These patients mostly had 
had a first operation, and most of them had recent onset 
of AF. I believe that your results in reoperated patients 
are almost the same as in the first operation, the differ- 
ence being that in that cohort you were operating mostly 
in patients with chronic AF. If this is so, in your opinion, 
is it justifiable tO do the operation in patients with mitral 
valve disease and AF of recent onset? 
Dr. Kobayashi. Some patients with mitral valve disease 
who have sinus rhythm in the preoperative period will 
have AF in the follow-up period. Thus we had better do 
the maze procedure in patients with recently occurring 
AF. In our modification we resect he right atrium and the 
left atrium and make the compartment smaller than 4 cm 
in width for advanced valvular heart disease. This is very 
important to restore sinus rhythm if the left atrium is very 
enlarged and also if the right atrium is enlarged owing to 
tricuspid regurgitation. 
